Tag

Psilocybin Therapy

All articles tagged with #psilocybin therapy

health2 years ago

EU Funds €6.5M Multi-Site Psilocybin Study for Palliative Patients

The European Union has granted €6.5 million to fund a multi-site study, called PsyPal, to investigate the use of psilocybin therapy in addressing psychological and existential distress in patients with progressive illnesses such as multiple sclerosis, chronic obstructive pulmonary disorder, atypical Parkinsonism, and amyotrophic lateral sclerosis. The study, which is the first of its kind in Europe, aims to enroll 100 patients across four clinical sites and will explore the safety, efficacy, and cost-effectiveness of psilocybin therapy in non-oncology palliative care. The project involves a consortium of 19 European organizations and is expected to commence in 2025, with results anticipated in 2027.

health2 years ago

Exploring the Therapeutic Potential of Psilocybin for Mental Health Conditions

A meta-analysis of 13 randomized controlled trials has highlighted the potential of psilocybin-assisted psychotherapy as a treatment for patients with treatment-resistant depression. The analysis found that patients receiving psilocybin therapy showed significantly more improvement in depressive symptoms compared to those who did not receive the treatment. Response rates and remission rates were higher in the psilocybin group, and the positive effects of psilocybin therapy were observed shortly after administration and could last for several months. While psilocybin was generally well-tolerated, some participants experienced non-serious side effects. However, careful screening and monitoring of participants, especially those with a complex psychiatric history, is necessary. Further research is needed to establish psilocybin-assisted psychotherapy as an accepted medical alternative.

health2 years ago

Psilocybin Therapy Shows Promise in Treating Alcohol Addiction: Study

A first-of-its-kind analysis has revealed how psilocybin therapy helps treat alcohol addiction. Researchers at NYU, UC San Francisco, and Fluence investigated the therapeutic mechanisms that led a cohort of people with alcohol use disorders (AUDs) to significantly reduce negative drinking behavior after participating in an earlier landmark psilocybin clinical trial. The study revealed several common themes among participants that could help inform future research and therapeutic applications as more states move to promote psychedelic studies and regulated access.